Clincosm LogoSign in Get a demo

Non-Hodgkin's Lymphoma

Showing NaN - NaN of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

DLBCL, Chronic Lymphocytic Leukemia, B Cell Malignancies Trial in Australia, United States (ABBV-525)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • +3 more
  • Louisville, Kentucky
  • +6 more
Nov 14, 2022

Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease Trial in Houston (EBV-specific T cells: A, EBV-specific T

Recruiting
  • Hodgkin's Disease
  • +3 more
  • EBV-specific T cells: A
  • EBV-specific T cells: B
  • Houston, Texas
  • +1 more
Jun 28, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Non-Hodgkin's Lymphoma Trial in United States (CG-806)

Recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Phoenix, Arizona
  • +30 more
Mar 28, 2022

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Oklahoma City, Houston (Fenretinide,

Terminated
  • Acute Myelogenous Leukemia
  • +2 more
  • Oklahoma City, Oklahoma
  • +1 more
Mar 17, 2022

Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in Chapel Hill, Houston (CAR.CD30 T cells)

Active, not recruiting
  • Non-Hodgkin's Lymphoma
  • Hodgkin's Lymphoma
  • CAR.CD30 T cells
  • Chapel Hill, North Carolina
  • +2 more
Mar 16, 2022

Non-Hodgkin's Lymphoma, B-Cell ALL, B-Cell CLL Trial in Houston (CD19.CAR-CD28Z T Cells - dose escalation 2, CD19.CAR-CD28Z T

Recruiting
  • Non-Hodgkin's Lymphoma
  • +2 more
  • CD19.CAR-CD28Z T Cells - dose escalation 2
  • CD19.CAR-CD28Z T Cells - dose escalation 1
  • Houston, Texas
  • +1 more
Feb 10, 2022

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Houston (autologous CAR.CD30 EBV specific-CTLs)

Active, not recruiting
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • autologous CAR.CD30 EBV specific-CTLs
  • Houston, Texas
  • +1 more
Feb 4, 2022

Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia Trial in United States (hLL1-DOX (IMMU-115))

Terminated
  • Non-Hodgkin's Lymphoma
  • Chronic Lymphocytic Leukemia
  • hLL1-DOX (IMMU-115)
  • Newark, Delaware
  • +5 more
Oct 6, 2021

Non-Hodgkin's Lymphoma Trial in New York, Philadelphia, Houston (hA20-humanized anti-CD20 antibody)

Completed
  • Non-Hodgkin's Lymphoma
  • hA20-humanized anti-CD20 antibody
  • New York, New York
  • +2 more
Aug 12, 2021

Non-Hodgkin's Lymphoma Trial in United States (ABT-199, Rituximab, Bendamustine)

Completed
  • Non-Hodgkin's Lymphoma
  • La Jolla, California
  • +7 more
Jul 29, 2021

Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in Worldwide (HCD122)

Completed
  • Non-Hodgkin's Lymphoma
  • Hodgkin's Lymphoma
  • Chicago, Illinois
  • +27 more
Dec 11, 2020

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Infusion of one MPC

Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • Infusion of one MPC expanded cord unit and one unexpanded cord unit
  • Infusion of two unexpanded cord blood units.
  • Miami, Florida
  • +8 more
Jun 25, 2020

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

Completed
Has Results
  • B-cell Chronic Lymphocytic Leukemia
  • +9 more
  • Stanford, California
  • +15 more
May 14, 2020

Hematological Tumors, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in United States (CC-486, Vidaza)

Completed
  • Hematological Neoplasms
  • +19 more
  • Scottsdale, Arizona
  • +9 more
May 11, 2020

Non-Hodgkin's Lymphoma Trial in Worldwide (Obinutuzumab, Bendamustine)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Mobile, Alabama
  • +120 more
Dec 20, 2019

Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Ublituximab + TGR-1202, Ublituximab + TGR-1202 +

Completed
  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin's Lymphoma
  • Ublituximab + TGR-1202
  • +2 more
  • Huntsville, Alabama
  • +5 more
Nov 4, 2019

Follicular Lymphoma, B-cell Lymphoma, Non-Hodgkin's Lymphoma Trial in United States (Ibrutinib, rituximab)

Completed
Has Results
  • Follicular Lymphoma
  • +2 more
  • Burbank, California
  • +11 more
Mar 26, 2019

Non-Hodgkin's Lymphoma Trial in Houston (Filgrastim SD/01, Paclitaxel, Topotecan)

Completed
  • Non-Hodgkin's Lymphoma
  • Filgrastim SD/01
  • +2 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Oct 29, 2018

Breast Cancer, Hypercalcemia of Malignancy, Colon Cancer Trial in Worldwide (denosumab)

Completed
Has Results
  • Breast Cancer
  • +15 more
  • Encinitas, California
  • +23 more
Sep 20, 2018

Non-Hodgkin's Lymphoma Trial in Worldwide (Ofatumumab, Rituximab)

Terminated
Has Results
  • Non-Hodgkin's Lymphoma
  • Ofatumumab
  • Rituximab
  • Anchorage, Alaska
  • +154 more
Apr 16, 2018

Cutaneous T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Worldwide (belinostat)

Terminated
Has Results
  • Cutaneous T-Cell Lymphoma
  • +2 more
  • Stanford, California
  • +14 more
Jul 7, 2015

Non-Hodgkin's Lymphoma Trial in Worldwide (obinutuzumab (RO5072759), rituximab)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Los angeles, California
  • +70 more
Aug 15, 2014

Non-Hodgkin's Lymphoma Trial in Canada, United States (SDX-105)

Completed
  • Non-Hodgkin's Lymphoma
  • Birmingham, Alabama
  • +16 more
May 8, 2014

Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma Trial in Czech Republic, Russian Federation, United

Terminated
  • Non-Hodgkin's Lymphoma
  • +2 more
  • San Francisco, California
  • +19 more
Jan 3, 2014

Non-Hodgkin's Lymphoma, Lymphoma Trial in Houston (Rituximab, Zevalin)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Lymphoma
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 4, 2013